Marc-Henri Stern

The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer.

Genetic landscape of uveal melanoma.

Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions.

Ovarian Cancers Harboring Inactivating Mutations in CDK12 Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications.

Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage.

Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.

Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

ATM Gene Mutation Detection Techniques and Functional Analysis.

Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA.

A GWAS in uveal melanoma identifies risk polymorphisms in the locus.

Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.

Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function.

Location of Mutation in Gene and Survival in Patients with Ovarian Cancer.

Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR.

Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers.

[Uveal melanoma, a model disease for splicing alterations and oncogenesis].

Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors.

Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy.

Medullary Breast Carcinoma, a Triple-Negative Breast Cancer Associated with BCLG Overexpression.

PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers.